| Affiliation: | 1. Department of Molecular Medicine, Lipid Clinic and Atherosclerosis Prevention Centre, ‘Umberto I’ Hospital - ‘Sapienza’ University of Rome, Rome, Italy;2. Department of Internal Medicine - Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy;3. Department of Food and Drug, University of Parma, Parma, Italy;4. Endocrinology and Metabolic Diseases, Civile Maggiore Hospital of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;5. Immunohematology and Transfusion Medicine, ASL3, Pistoia, Italy;6. Department of Internal Medicine, University of Genoa, Italy;7. Department of Life Sciences, University of Parma, Italy;8. Inserm UMR_S1140 “Innovative Therapies in Haemostasis” Faculté de Pharmacie de Paris, Université Paris Descartes, Paris, France;9. French Institute of Health and Medical Research (Inserm), France;10. Department of Medicine, Northwest Lipid Research Laboratories, University of Washington, Seattle, WA, USA;11. School of Medicine, Faculty of Health and Medical Sciences - Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital University of Western Australia, Perth, Western Australia, Australia;1. School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia;2. PathWest Laboratory Medicine, QEII, Perth, WA and Pathology and Laboratory Medicine, University of Western Australia, Perth, WA;3. Faculty of Engineering, Computing and Mathematics, University of Western Australia, Perth, WA, Australia |
